Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)

Publication date: Available online 15 April 2021Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): H. James Wedner, Emel Aygören-Pürsün, Jonathan Bernstein, Timothy Craig, Richard Gower, Joshua S. Jacobs, Douglas T. Johnston, William Lumry, Bruce L. Zuraw, Jessica M. Best, Heather A. Iocca, Sharon C. Murray, Bhavisha Desai, Eniko Nagy, William P. Sheridan, Sorena Kiani-Alikhan
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research